NVNO
enVVeno Medical Corp
8.20$
-2.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +73.1% | -7.8% | -8.6% | +22.9% | -10.8% | -9.7% | -9.9% | -11.6% | -8.6% | -11.7% | -13.2% | |
| – | +79.0% | -7.8% | -8.6% | +24.1% | -10.8% | -9.7% | -9.8% | -11.5% | -8.5% | -11.6% | -13.4% | |
| – | -26.8% | -36.1% | +2.9% | +652.7% | -90.2% | +67.4% | -30.4% | -24.5% | +98.5% | -15.3% | +9.4% | |
| – | +80.6% | -7.5% | -9.0% | +23.8% | -10.8% | -9.8% | -9.8% | -11.9% | -8.9% | -11.6% | -13.8% | |
| – | -23.4% | +1.0% | +4.8% | +17.2% | -7.5% | -18.8% | +55.1% | -17.5% | -16.3% | -3.4% | -15.3% | |
| – | -32.5% | +8.5% | +14.0% | +31.5% | -6.0% | -20.7% | +81.5% | -20.4% | -11.6% | +1.0% | -11.9% | |
| – | +2.1% | +1.8% | +2.0% | +1.7% | +2.0% | +1.6% | +1.9% | -24.1% | +36.4% | +1.5% | +1.5% | |
| – | -65.4% | +41.5% | +15.6% | +28.1% | +12.5% | -30.1% | +52.6% | -41.7% | -42.8% | +127.1% | -33.6% | |
| – | +85.4% | -8.3% | -9.3% | +23.3% | -11.0% | -9.1% | -13.7% | -10.9% | -7.9% | -12.5% | -13.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.6% | +20.6% | +0.1% | +0.0% | +26.8% | -0.1% | +0.0% | -1.0% | +0.0% | +3,875.0% | +2.6% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.